Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
主要作者: | Akter, Anika |
---|---|
其他作者: | Alam, Marzia |
格式: | Thesis |
語言: | English |
出版: |
Brac University
2022
|
主題: | |
在線閱讀: | http://hdl.handle.net/10361/17039 |
相似書籍
-
Biologics and Biosimilars as Treatment Options for Psoriasis
由: Moya, Amena Khatun
出版: (2023) -
Importance of biologics in rheumatoid arthritis management
由: Riyadh, S. M.
出版: (2022) -
TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
由: Afroza, Halima
出版: (2024) -
Importance of biologically active agents over other therapies in Rheumatoid Arthritis- a review
由: Mehreen, Elnaj
出版: (2021) -
A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
由: Islam, Nahidul
出版: (2023)